Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Ogbudebe, C."'
Autor:
Odume B; KNCV Tuberculosis Foundation, Abuja, Nigeria., Ogbudebe C; KNCV Tuberculosis Foundation, Abuja, Nigeria., Mukadi Y; United States Agency for International Development (USAID), Washington, DC, USA., Dim C; College of Medicine, University of Nigeria, Ituku-Ozalla, Nigeria., Chukwu E; KNCV Tuberculosis Foundation, Abuja, Nigeria., Chukwuogo O; KNCV Tuberculosis Foundation, Abuja, Nigeria., Useni S; KNCV Tuberculosis Foundation, Abuja, Nigeria., Nwokoye N; KNCV Tuberculosis Foundation, Abuja, Nigeria., Sheshi M; KNCV Tuberculosis Foundation, Abuja, Nigeria., Nongo D; USAID, Abuja, Nigeria., Eneogu R; USAID, Abuja, Nigeria., Ihesie A; USAID, Abuja, Nigeria., Ubochioma E; National TB, Leprosy and Buruli Ulcer Control Programme, Federal Ministry of Health Nigeria, Abuja, Nigeria., Anyaike C; National TB, Leprosy and Buruli Ulcer Control Programme, Federal Ministry of Health Nigeria, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2024 Dec 01; Vol. 14 (4), pp. 181-185. Date of Electronic Publication: 2024 Dec 01 (Print Publication: 2024).
Autor:
Gordon I; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Odume B; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Ogbudebe C; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwuogo O; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Nwokoye N; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Useni S; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Efo E; KNCV TB Plus, The Hague, Netherlands., Gidado M; KNCV TB Plus, The Hague, Netherlands., Aniwada E; Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu., Ihesie A; United States Agency for International Development (USAID), Abuja., Nongo D; United States Agency for International Development (USAID), Abuja., Eneogu R; United States Agency for International Development (USAID), Abuja., Chijioke-Akaniro O; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2024 Jun 01; Vol. 14 (2), pp. 61-65. Date of Electronic Publication: 2024 Jun 01 (Print Publication: 2024).
Autor:
Ogbudebe C; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Odume B; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Gordon I; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwuogo O; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Nwokoye N; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Useni S; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Efo E; KNCV TB Plus, The Hague Netherlands., Gidado M; KNCV TB Plus, The Hague Netherlands., Aniwada E; Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu., Ihesie A; United States Agency for International Development (USAID), Abuja, Nigeria., Nongo D; United States Agency for International Development (USAID), Abuja, Nigeria., Eneogu R; United States Agency for International Development (USAID), Abuja, Nigeria., Chijioke-Akaniro O; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2024 Jun 01; Vol. 14 (2), pp. 66-70. Date of Electronic Publication: 2024 Jun 01 (Print Publication: 2024).
Autor:
Nwokoye N; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Odume B; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Nwadike P; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Anaedobe I; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Mangoro Z; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Umoren M; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Ogbudebe C; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Chukwuogo O; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Useni S; Technical Department, KNCV Nigeria, Abuja 900103, Nigeria., Nongo D; Program Management Department, HIV/AIDS & TB Office, USAID, Abuja 900103, Nigeria., Eneogu R; Program Management Department, HIV/AIDS & TB Office, USAID, Abuja 900103, Nigeria., Elom E; The Programs and Coordination Department, National Tuberculosis, Leprosy & Buruli Ulcer Control Program, Abuja 904101, Nigeria., De Haas P; Technical Department, KNCV Tuberculosis Foundation, 2516 AB The Hague, The Netherlands., Gidado M; Technical Department, KNCV Tuberculosis Foundation, 2516 AB The Hague, The Netherlands.
Publikováno v:
Tropical medicine and infectious disease [Trop Med Infect Dis] 2024 May 01; Vol. 9 (5). Date of Electronic Publication: 2024 May 01.
Autor:
Mitchell EM; Mycobacterial Diseases and Neglected Tropical Diseases Unit, Department of Public Health, Institute for Tropical Medicine, Antwerp, Belgium., Adejumo OA; Mainland Hospital, Yaba Lagos, Nigeria.; Department of Community Health and Primary Health Care, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Abdur-Razzaq H; Health Research Unit, Directorate of Planning, Research, and Statistics, Lagos Ministry of Health, Lagos, Nigeria., Ogbudebe C; KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Gidado M; KNCV Tuberculosis Foundation, The Hague, Netherlands.
Publikováno v:
JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Apr 25; Vol. 10, pp. e52191. Date of Electronic Publication: 2024 Apr 25.
Autor:
Eneogu RA; United States Agency for International Development (USAID), Abuja, Nigeria., Mitchell EMH; Mycobacterial Diseases and Neglected Tropical Diseases Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium., Ogbudebe C; KNCV TB Foundation, Abuja, Nigeria., Aboki D; Nasarawa State TB and Leprosy Control Program, Nasarawa, Nigeria., Anyebe V; KNCV TB Foundation, Abuja, Nigeria., Dimkpa CB; KNCV TB Foundation, Abuja, Nigeria., Egbule D; Nasarawa State TB and Leprosy Control Program, Nasarawa, Nigeria., Nsa B; McMaster University, Ontario, Canada., van der Grinten E; KNCV TB Foundation, The Hague, Netherlands., Soyinka FO; Ogun State Ministry of Health, Ogun, Nigeria., Abdur-Razzaq H; Lagos State Ministry of Health, Lagos, Nigeria., Useni S; KNCV TB Foundation, Abuja, Nigeria., Lawanson A; National TB and Leprosy Program, Federal Ministry of Health Nigeria, Abuja, Nigeria., Onyemaechi S; National TB and Leprosy Program, Federal Ministry of Health Nigeria, Abuja, Nigeria., Ubochioma E; National TB and Leprosy Program, Federal Ministry of Health Nigeria, Abuja, Nigeria., Scholten J; KNCV TB Foundation, The Hague, Netherlands., Verhoef J; KNCV TB Foundation, The Hague, Netherlands., Nwadike P; KNCV TB Foundation, The Hague, Netherlands., Chukwueme N; New York Medical College, New York, NY, United States of America., Nongo D; United States Agency for International Development (USAID), Abuja, Nigeria., Gidado M; KNCV TB Foundation, The Hague, Netherlands.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2024 Jan 17; Vol. 4 (1), pp. e0002018. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ogbudebe C; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Jeong D; University of Texas, Dallas, TX, United States., Odume B; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Chukwuogo O; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Dim C; College of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria., Useni S; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Okuzu O; InStrat Global Health Solutions, Abuja, Nigeria., Malolan C; University of Texas Southwestern Medical Center, Dallas, TX, United States., Kim D; University of Texas, Dallas, TX, United States., Nwariaku F; University of Texas Southwestern Medical Center, Dallas, TX, United States., Nwokoye N; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Gande S; Technical Division, KNCV Tuberculosis Foundation, Abuja, Nigeria., Nongo D; Office of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Tuberculosis, United States Agency for International Development, Abuja, Nigeria., Eneogu R; Office of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Tuberculosis, United States Agency for International Development, Abuja, Nigeria., Odusote T; Office of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Tuberculosis, United States Agency for International Development, Abuja, Nigeria., Oyelaran S; Office of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Tuberculosis, United States Agency for International Development, Abuja, Nigeria., Chijioke-Akaniro O; National Tuberculosis, Leprosy and Buruli Ulcer Control Program, Federal Ministry of Health, Abuja, Nigeria., Nihalani N; Plus91 Technologies, Delhi, India., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Program, Federal Ministry of Health, Abuja, Nigeria., Gidado M; Program Management Unit, KNCV Tuberculosis Foundation, Hague, Netherlands.
Publikováno v:
JMIR public health and surveillance [JMIR Public Health Surveill] 2023 Feb 08; Vol. 9, pp. e40311. Date of Electronic Publication: 2023 Feb 08.
Autor:
Odume B; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwu E; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Fawole T; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Nwokoye N; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Ogbudebe C; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Chukwuogo O; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Useni S; Technical Division, KNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria., Dim C; College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu State, Nigeria., Ubochioma E; National Tuberculosis, Leprosy and Buruli Ulcer Control Program, Federal Ministry of Health Public Health, Abuja, Nigeria., Nongo D; TB/HIV Unit, HIV/AIDS & TB Office USAID Nigeria, Abuja, Nigeria., Eneogu R; TB/HIV Unit, HIV/AIDS & TB Office USAID Nigeria, Abuja, Nigeria., Lagundoye Odusote T; TB/HIV Unit, HIV/AIDS & TB Office USAID Nigeria, Abuja, Nigeria., Oyelaran O; TB/HIV Unit, HIV/AIDS & TB Office USAID Nigeria, Abuja, Nigeria., Anyaike C; National Tuberculosis, Leprosy and Buruli Ulcer Control Program, Federal Ministry of Health Public Health, Abuja, Nigeria.
Publikováno v:
Public health action [Public Health Action] 2022 Jun 21; Vol. 12 (2), pp. 85-89.
Autor:
Gidado, M.1, Odume, B.2, Ogbudebe, C.2 cogbudebe@kncvnigeria.org, Useni, S.2, Tukur, M.2, Chukwuogo, O.2, Ajiboye, P.2, Sadiq, I.3, Yahaya, K.4, Adebola, L.5
Publikováno v:
African Journal of Respiratory Medicine. 2020, Vol. 15 Issue 2, p18-23. 6p.